Ensuring global access to COVID-19 vaccines
- PMID: 32243778
- PMCID: PMC7271264
- DOI: 10.1016/S0140-6736(20)30763-7
Ensuring global access to COVID-19 vaccines
References
-
- Ferguson NM, Laydon D, Nedjati-Gilani G, et al. Imperial College COVID-19 Response Team Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. March 16, 2020. https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-... - PMC - PubMed
-
- Ahmed K. World's most vulnerable in “third wave” for COVID-19 support, experts warn. The Guardian. March 20, 2020
-
- Yamey G, Schäferhoff M, Pate M, et al. Funding the development and manufacturing of COVID-19 vaccines: background paper for the World Bank/CEPI financing COVID-19 vaccine development consultation on February 20, 2020. http://centerforpolicyimpact.org/our-work/our-publications/funding-devel...
-
- The Coalition for Epidemic Preparedness Innovations $2 billion required to develop a vaccine against the COVID-19 virus. March 14, 2020. https://cepi.net/news_cepi/2-billion-required-to-develop-a-vaccine-again...
-
- National Institutes of Health NIH clinical trial of investigational vaccine for COVID-19 begins. March 16, 2020. https://www.nih.gov/news-events/news-releases/nih-clinical-trial-investi...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical